Meta-Analysis
Copyright ©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Oct 28, 2013; 19(40): 6919-6927
Published online Oct 28, 2013. doi: 10.3748/wjg.v19.i40.6919
Table 1 Characteristics of included studies
Ref.DesignRegionsTarget populationInterventionOutcome measures
Blair et al[25]Single center RCTLondon, United KingdomAcute severe UGIB; no esophageal varicesEarly transfusion group (liberal transfusion): at least 2 units of blood No transfusion group (restrictive transfusion): no blood transfusion unless hemoglobin fell below 8 g/dL or they were shockedObserved results: coagulation results (impedance clotting time, kaolin cephalin clotting time); haematological results (hematocrit); eventual blood transfused; number of rebleed; number of death
Elizalde et al[24]Single center RCTBarcelona, SpainLiver cirrhosis with an acute variceal bleeding episodePRC group (liberal transfusion): 2 units of packed red cells PPL group (restrictive transfusion): 500 mL of a 5% plasma protein solutionObserved items: hemodynamic measurements (cardiopulmonary pressures, cardiac output, wedged and free hepatic venous pressures, mean arterial blood pressure, systemic vascular resistance); hormonal measurements (plasma renin activity, aldosterone levels, norepinephrine); rheological parameters (plasma volume, blood viscosity)
Villarejo et al[23]Single center RCTBuenos Aires, ArgentinaAcute digestive hemorrhage with stable haemodynamicsTreatment group (restrictive transfusion): patients underwent normovolemic hemodilution with crystalloid solutions, and the hematocrit value was maintained as ≥ 21% and < 28%; red cell transfusion was given if angina, shock, hemodynamic instability, or hematocrit < 21% Control group (liberal transfusion): the target of transfusion in these patients was the hematocrit value of ≥ 28%Observed results: organ failure, hospital stay, APACHE II score, red cell transfused, hematocrit, haemoglobin
Villanueva et al[14]Single center RCTBarcelona, SpainUpper gastrointestinal bleedingLiberal transfusion: the hemoglobin threshold for transfusion was 9 g/dL, with a target range for the post-transfusion hemoglobin level of 9-11 g/dL Restrictive transfusion: the hemoglobin threshold for transfusion was 7 g/dL, with a target range for the post-transfusion hemoglobin level of 7-9 g/dLPrimary endpoints: the rate of death from any cause within the first 45 d Secondary endpoints: the rate of further bleeding and the rate of in-hospital complications
Table 2 Eligibility criteria of included studies
Ref.Eligibility criteria
Blair et al[25]Consecutive patients with acute severe upper gastrointestinal haemorrhage were prospectively randomized on arrival to receive during their first 24 h in hospital
Only known cases of oesophageal varices were excluded as they frequently have abnormal coagulation due to liver disease
Elizalde et al[24]The study population consisted of patients with cirrhosis of the liver admitted for the management of an acute variceal bleeding episode
Only patients in whom hemostasia had been achieved within the previous 24-72 h by means of endoscopic sclerotherapy, and who were still anemic (hematocrit < 30%) and normovolemic as defined by clinical parameters (systolic pressure > 100 mmHg, right atrial pressure > 2 cm H2O, heart rate < 100 beats/min, and urine output > 0.5 mL/kg per hour) were eligible for the study
Age < 18 or > 80 yr, renal failure as defined as serum creatinine > 2 mg/dL, portal thrombosis, diffuse or multinodular hepatocellular carcinoma, arterial hypertension, peripheral vasculopathy, previous surgical or transjugular intrahepatic portosystemic shunt, bacterial infection, and use of vasoactive drugs to prevent or treat portal hypertension-related bleeding were considered exclusion criteria
Villarejo et al[23]Inclusion criteria: acute high digestive haemorrhage with stable haemodynamics and any aetiology; age > 15 yr old
Exclusion criteria: history of angina; shock not responsive to volume expansion; requirement of surgery; established renal insufficiency; poliglobulina; bleeding diathesis; acute or chronic liver dysfunction; chronic anemia; pregnancy; sepsis; acute or chronic respiratory failure; haematocrit < 20% on admission; religious objection to transfusion
Villanueva et al[14]Patients older than 18 yr of age who had hematemesis (or bloody nasogastric aspirate), melena, or both, as confirmed by the hospital staff, were considered for inclusion
Patients were excluded if they declined to undergo a blood transfusion
Additional exclusion criteria: massive exsanguinating bleeding, an acute coronary syndrome, symptomatic peripheral vasculopathy, stroke, transient ischemic attack, or transfusion within the previous 90 d; a recent history of trauma or surgery; lower gastrointestinal bleeding; a previous decision on the part of the attending physician that the patient should avoid specific medical therapy; and a clinical Rockall score of 0 with a hemoglobin level >12 g/dL
Table 3 Baseline characteristics of patients in included studies
Ref.GroupsNo. PatientsAge (yr)Sex (male:female)Source of bleedingHematocrit atadmissionHemoglobin atadmission (g/dL)
Blair et al[25]Restrictive transfusion2660 ± 4.52:1Gastric ulcer (n = 4); duodenal ulcer (n = 13); carcinoma (n = 2); Mallory-Weiss tear (n = 3); not visualized (n = 4)29 ± 1.6NA
Liberal transfusion2464 ± 3.62:1Gastric ulcer (n = 2); duodenal ulcer (n = 17); carcinoma (n = 1); Mallory-Weiss tear (n = 2); not visualized (n = 2)28 ± 1.2NA
Elizalde et al[24]Restrictive transfusion860 ± 45/3Bleeding from esophageal varices (n = 7); bleeding from gastric varices in the fundus of the stomach (n = 1)27.0 ± 1.391.5 ± 6.8
Liberal transfusion864 ± 24/4Bleeding from esophageal varices (n = 7); bleeding from gastric varices in the fundus of the stomach (n = 1)27.0 ± 1.390.5 ± 3.96
Villarejo et al[23]Restrictive transfusion1456.8 ± 12.89/5Mallory Weiss (n = 2); erosive gastritis (n = 14); erosive gastroduodenitis (n = 4); Forrest gastric ulcer (n = 10); Forrest duodenal ulcer (n = 10); erosive duodenitis (n = 1)26.9 ± 4.298.76 ± 2.47
Liberal transfusion1345.3 ± 14.69/428.3 ± 5.598.85 ± 2.53
Villanueva et al[14]Restrictive transfusion444NANAPeptic ulcer (n = 228); gastroesophageal varices (n = 101); Mallory-Weiss tears (n = 25); erosive gastritis or esophagitis (n = 38); neoplasms (n = 16); other (n = 36)NA9.6 ± 2.2
Liberal transfusion445NANAPeptic ulcer (n = 209); gastroesophageal varices (n = 109); Mallory-Weiss tears (n = 30); erosive gastritis or esophagitis (n = 29); neoplasms (n = 20); other (n = 48)NA9.4 ± 2.4
Table 4 Quality assessment of included studies
Ref.RandomizationBlindingWithdrawals and dropoutsJadad Score
Blair et al[25]Yes (inadequate)NoUnclear1
Elizalde et al[24]Yes (inadequate)UnclearUnclear1
Villarejo et al[23]Yes (adequate)UnclearClear3
Villanueva et al[14]Yes (adequate)UnclearClear3